alexa Retinal Laser Therapy: Recent Unique Developments Behind the Brilliant Front Stage of Anti-VEGF Treatment | OMICS International
ISSN: 2155-9570
Journal of Clinical & Experimental Ophthalmology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Retinal Laser Therapy: Recent Unique Developments Behind the Brilliant Front Stage of Anti-VEGF Treatment

Yoko Miura*
Senior Researcher/Principle investigator, University of Luebeck, Germany
Corresponding Author : Yoko Miura
Senior Researcher/Principle investigator
University of Luebeck, Germany
Tel: +49 (0)451 500 6527
E-mail: [email protected]
Received November 25, 2014; Accepted November 26, 2014; Published November 29, 2014
Citation: Miura Y (2014) Retinal Laser Therapy: Recent Unique Developments Behind the Brilliant Front Stage of Anti-VEGF Treatment. J Clin Exp Ophthalmol 5:e114. doi: 10.4172/2155-9570.1000e114
Copyright: © 2014 Miura Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Clinical & Experimental Ophthalmology

Retinal Laser Therapy

“What does laser do on the retina?” “It is easy. It just destroys the RPE and surrounding tissues including photoreceptors.” “For what?” “…to reduce oxygen consumptions mainly by photoreceptor outer segments in ischemic diseases, sometimes to coagulate retinal aneurisms, and to strengthen the retinal adhesion around the retinal holes or tears in order to avoid progression of retinal detachment”. It was the almost perfect answer, even still not completely proven, at least it was the enough knowledge in daily clinical practice before. But today, we are facing to the necessity to know more in detail, for example, “What happens if the RPE cells are just warmed up to 45°C for 0.1s?”, which we have almost never needed to consider before.

With the dramatic development of anti-VEGF treatment, it cannot be denied that necessity of retinal laser treatment has been reduced to some extent, although some retinal conditions still definitely require laser treatment. In particular, macular edema, through whatever the reason, is now treated mostly pharmacologically using anti-VEGF agents or corticosteroids, and the laser treatment, as grid photocoagulation, has been less and less performed in these days.

It is certainly understandable that photocoagulation on the macula is surely with high risk of eventual central or paracentral scotoma, which nobody wishes. But what if the damage extent is controllable below the significant damage threshold?

What has been used for a long time as a Merkmal of retinal photocoagulation was the mild whitening of the irradiated retina. It is now widely known that the apparent whitening may be a feature of the quite strong coagulation, which might involve the inner retina. The laser photocoagulation, which is not visible (=sub-visible) with funduscopy is so far called widely in clinical ophthalmology a “sub-threshold photocoagulation”. Different new technologies have been introduced for the successful sub-visible photocoagulation; micropulse laser photocoagulation, which utilizes the microsecond-range pulse in order to avoid steep temperature increase at the irradiated site [1], and the endpoint management laser system, which utilizes 577 nm laser irradiation and its endpoint algorithms to automatically adjust the irradiated energy (power and time) according to the desired damage strength [2]. They have shown positive clinical effects in treatment of macular edema without leaving severe central scotoma [3]. These new technologies have surely changed clinicians’ awareness in regard of the damage strength of retinal photocoagulation, and patients may obtain surely softer but effective treatment.

Desire to know is the motivation of science. The question has been always asked in the study field of retinal laser irradiation, “how much is the retinal temperature during irradiation on patients?” In retinal photocoagulation, the temperature and the time of the increased temperature are the major determinants of cell responses to the thermal stimulation. A working group in University of Luebeck has enabled the real-time temperature determination during photocoagulation using optoacoustic technique [4], and their online control system rather enables the automatic laser shut-off at the time point when the local temperature reaches the set temperature (AutoPhoN: Automatic Photocoagulation of the Retina) [5]. Intra-individual difference in pigmentation and other factors affecting laser absorption may alter the temperature increase among spots. This problem might be minimized by the installation of this system.

This AutoPhoN technique may also realize the controlled “sub-lethal” irradiation. In other words, non-invasive hyperthermia (photothermal) treatment on RPE cells is theoretically possible as one of the therapeutic options along with the lethal irradiation. Since sub-lethal laser-induced hyperthermia on the RPE under temperature control is a new concept, temperature-resolved RPE cell responses have been studied quite little to date [6]. We currently attempt to elucidate the temperature-dependent RPE cell responses in order to find optimal thermal dose for the beneficial hyperthermia treatment on the RPE [6]. Hyperthermia-induced cell functional manipulation is of our great interest. By the way, the term of “sub-threshold” is being gradually replaced recently by “sub-visible” or “sub-lethal” to avoid the confusion.

In retinal laser therapy, the time may come in the near future, when we ask by ourselves, “With which temperature do you want to treat this patient’s retina?
 
References







 

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 11733
  • [From(publication date):
    December-2014 - Jul 19, 2018]
  • Breakdown by view type
  • HTML page views : 7969
  • PDF downloads : 3764
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7